ERBB2/EGFR2/CD340 (Margetuximab biosimilar) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-ERBB2/EGFR2/CD340 (Margetuximab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityERBB2/EGFR2/CD340 (Margetuximab biosimilar)
Clonemonoclonal
Host SpeciesChimeric Human/Mouse
Reactive Specieshuman
IsotypeIgG1 kappa
FormatProtein A/G purified
Size100 µg, 1 mg,
Concentrationtypically between 0.5-2.0 mg/ml.
ApplicationsELISA, WB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionMargetuximab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ERBB2/EGFR2/CD340, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Margetuximab is under investigation in clinical trial NCT03133988 (Margetuximab Expanded Access Program).
Immunogenn/a
Other NamesMargetuximab, ERBB2/EGFR2/CD340, 1350624-75-7
Gene, Accession #CAS: 1350624-75-7
Catalog #abx831290
Priceplease inquire
Order / More InfoERBB2/EGFR2/CD340 (Margetuximab biosimilar) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.